Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 50
Filter
1.
Arch Mal Coeur Vaiss ; 96 Spec No 3: 35-41, 2003 Apr.
Article in French | MEDLINE | ID: mdl-12741330

ABSTRACT

UNLABELLED: The effect of 50 Hz and 60 Hz (frequencies of current distribution) and 20 kHz to 50 kHz (frequencies of induction cooktop) magnetic interference on implanted pacemakers have been assessed with the present generation of device technology. Sixty patients implanted in 1998 and 1999 with dual chamber pacemakers from 9 different manufacturers were monitored with telemetry while passing through, and standing between a system of two coils. They generated a 50 Hz or a 60 Hz magnetic field at 50 microT. Then, patients used a cooktop at different power. The recordings were made with the standard setting of "medically correct" sensing parameters chosen for the patients. Then pacemakers were reprogrammed to the unipolar mode, with the highest atrial (A) and ventricular (V) sensitivity that did not induce muscular inhibition while moving. Between each exposure (50 Hz, 60 Hz or 20 kHz to 50 kHz), the pacemaker programmation was controlled. At the end of the tests, pacemakers will be reprogrammed with the standard setting. The medical observer being blind to the existence or not of the magnetic field. No pacemaker was influenced by the vicinity of the magnetic field at medically correct settings. At unipolar high sensitivity, no inhibition nor reprogramming was observed. Transient reversion to interference mode was observed in 6 cases, 3 transient acceleration due to atrial detection of the interference, and one T wave detection by the ventricular lead. All were observed with the 60 Hz, and only 3 with the 50 Hz magnetic field. One device (Biotronik) shifted out of its special program (hysteresis research) during the tests with the induction cooktop, but it maintained its standard program, and the event could not be repeated despite further testing. CONCLUSION: Actual pacemakers do not present any electromagnetic interference with 50 Hz and 60 Hz or induction cooktop frequency working. They are insensitive with medically correct settings. Unusual high sensitivity leads only to noise reversion mode, or transient ventricular tracking.


Subject(s)
Electromagnetic Fields , Pacemaker, Artificial , Dose-Response Relationship, Radiation , Equipment Design , Humans , Monitoring, Physiologic , Pacemaker, Artificial/adverse effects , Radio Waves , Telemetry
2.
Arch Mal Coeur Vaiss ; 96 Spec No 3: 46-9, 2003 Apr.
Article in French | MEDLINE | ID: mdl-12741332

ABSTRACT

The IRM is formally contraindicated to the pacemaker and cardiac defibrillator wearers because of the risk of inhibition or inappropriate stimulations during the examination. However if the examination is essential, suitable programming of the apparatus and a constant monitoring of the heartbeat rate by a qualified doctor in cardiac stimulation must make it possible to avoid any accident.


Subject(s)
Defibrillators, Implantable , Electromagnetic Fields , Pacemaker, Artificial , Radio Waves/adverse effects , Humans
3.
Pacing Clin Electrophysiol ; 23(11 Pt 2): 1798-800, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11139927

ABSTRACT

Active-fixation pacemaker leads enable pacing at various sites, have a low dislodgment rate, and are easier to extract than passive-fixation leads, though are usually not routinely implanted in the ventricle because of their higher pacing threshold. The long-term pacing threshold associated with an active-fixation steroid-eluting lead was prospectively measured in 18 women and 20 men. At a mean follow-up of 14 months (range 3-25 months), pacing threshold increased from 0.71 +/- 0.29 V to 0.96 +/- 0.28 V (P = 0.01) between implant and the first month of follow-up, then remained stable over time, consistently allowing the long-term programming of the ventricular output at 2.5 V, while lead impedance remained stable (from 647 +/- 161 omega at implant to 666 +/- 122 omega at last follow-up). If the long-term performance of this type of lead is confirmed, the routine implantation of ventricular steroid-eluting active-fixation leads should be considered since lead extraction has become a major concern.


Subject(s)
Arrhythmias, Cardiac/therapy , Cardiac Pacing, Artificial/methods , Dexamethasone/analogs & derivatives , Electrodes, Implanted/standards , Heart Ventricles/surgery , Pacemaker, Artificial , Adult , Aged , Aged, 80 and over , Arrhythmias, Cardiac/physiopathology , Chronic Disease , Dexamethasone/administration & dosage , Drug Implants , Female , Follow-Up Studies , Heart Ventricles/physiopathology , Humans , Male , Middle Aged , Prospective Studies , Sensory Thresholds , Treatment Outcome
4.
Ann Cardiol Angeiol (Paris) ; 49(4): 238-44, 2000 Jul.
Article in French | MEDLINE | ID: mdl-12555485

ABSTRACT

Cardiac pacemaker are sensitive to many kind of electromagnetic interference (EMI). However the low rate of reported effects is due to many protective features. Risks are minimal in everyday life conditions as airport detectors, electronic anti-thief systems, domestic electrical appliances and even mobile phones with the most recent models. Interference detection can be prevented by "medically correct" setting, with the use of bipolar sensing, and ventricular sensitivity above 2 mV. The effect of EMI from the industrial world are difficult to assess and need an individual study. The most important risks occur in the medical world, with the electrocutary, thransthoracic DC shocks, and magnetic resonance imaging.


Subject(s)
Electromagnetic Fields , Pacemaker, Artificial , Electromagnetic Fields/adverse effects , Equipment Design , Equipment Failure , Humans , Risk Factors
6.
Pacing Clin Electrophysiol ; 21(11 Pt 2): 2314-7, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9825339

ABSTRACT

UNLABELLED: To make recommendations for management of potentially fatal failure of the Accufix series of atrial J-wire permanent pacemaker leads, we closely monitored the number of injuries and fatalities resulting either from spontaneous fracture of the J-wire or from attempts to extract the lead. In a population of 30,357 patients, 2,298 patients are enrolled in a prospective follow-up Multicenter Study, the remainder are patients with known clinical status from voluntary reporting, and 2,992 patients died following implant. In the remaining 27,365 patients, 6 deaths have been attributed to J-wire related injury (J-inj) while 13 were complications (E-inj) associated with 4,076 lead extraction procedures (3,974 intravascular (intra)/102 primary thoracotomy (PT). The date of occurrences were from 1994 to November 1997. CONCLUSIONS: (1) Since lead extractions were not conducted in a controlled study, it is not known whether the deaths associated with lead extraction is in excess of what would have occurred if these leads had not been removed in this specific subset. (2) Awareness of the procedure related complication rate appears to have moderated the rate of lead extraction and may ultimately lead to management that reasonably balances the risks of patient injury.


Subject(s)
Electrodes, Implanted/adverse effects , Pacemaker, Artificial , Electrodes, Implanted/statistics & numerical data , Equipment Design , Equipment Failure/statistics & numerical data , Humans , Product Surveillance, Postmarketing , Prospective Studies
7.
Pacing Clin Electrophysiol ; 21(11 Pt 2): 2318-21, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9825340

ABSTRACT

UNLABELLED: Morbidity (36 cases) and mortality (6 cases) have been reported in patients with Accufix J retention wire atrial leads. This has resulted in ongoing patient fluoroscopic monitoring as well as lead extractions. The estimated implanted worldwide population is 40,860. Estimating the size of the remaining population at risk is an important tool for assessing patient management guidelines. RESULTS: The Kaplan-Meier method can be used to calculate the cumulative probability of remaining free of extraction and death for patients based on implant duration. The individual Kaplan-Meier curves for lead extraction and patient survival can also be computed. Based on the Multicenter Study (MCS) population of 2,298 patients, the probability that a patient is alive with the lead still implanted at 5 years implant duration is 52.5%. The event-free survival rate at 5 years implant duration is 81.3%. The corresponding probability of remaining free from injury due to the J-wire is 99.9% at 5 years implant duration. Assuming similar rates of death and extraction, these results can be extrapolated to the world wide population. CONCLUSIONS: The management of Accufix patients must consider patient longevity, the probability of J-wire morbidity/mortality, and the probability of extraction complication morbidity/mortality. The probability of remaining at risk as a function of time from implant can be calculated from the events known in the MCS patient population. These event-free survival estimates can be used to identify subsets of the population at greater or lesser risk based on various clinical parameters.


Subject(s)
Electrodes, Implanted/adverse effects , Pacemaker, Artificial/statistics & numerical data , Disease-Free Survival , Electrodes, Implanted/statistics & numerical data , Equipment Design , Equipment Failure/statistics & numerical data , Humans , Product Surveillance, Postmarketing , Risk Assessment
8.
Pacing Clin Electrophysiol ; 21(11 Pt 2): 2322-6, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9825341

ABSTRACT

UNLABELLED: To permit a more complete analysis of J-wire fracture in the Accufix series of atrial permanent pacemaker leads, the time to occurrence of all known fractures and injuries has been redefined relative to the duration of risk exposure, that is, according to the interval of time between implant and occurrence of the event. This redefinition permits application of a cumulative hazards model to the data, which previously has not been explored. Predictors of J-wire fracture can be tested using this method. This also permits parametric curve-fitting for determination of linearity or constancy of risk of events over time. RESULTS: Among 2,063 Multicenter Study (MCS) leads analyzed, 381 fractures of the J-wire were identified. Stratified analysis based on cumulative hazard curves identified a more open shape of the J-wire as predictive of fracture, which supports the results previously reported based on logistic regression analysis. Fitting a Weibull curve to the cumulative hazard of J-wire fracture gives a shape parameter equal to 0.85. This value indicates that the instantaneous hazard of J-wire fracture decreased over time from implant. CONCLUSIONS: (1) The cumulative hazard function can be used to examine predictors of J-wire fracture and preliminary findings support the previously identified predictor of J shape; (2) Based on these analyses, the rate of J-wire fracture appears to decrease slightly as time from implant increases.


Subject(s)
Electrodes, Implanted/adverse effects , Pacemaker, Artificial , Electrodes, Implanted/statistics & numerical data , Equipment Design , Equipment Failure/statistics & numerical data , Equipment Failure Analysis/statistics & numerical data , Humans , Linear Models , Product Surveillance, Postmarketing , Proportional Hazards Models , Risk Assessment , Time Factors
11.
Pacing Clin Electrophysiol ; 21(2): 485, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9507561
SELECTION OF CITATIONS
SEARCH DETAIL
...